• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

TomoTherapy extends French connection


Other headlines:Epix shakes up business leadership

TomoTherapy extends French connection

Centre Oscar Lambret in Lille, France, has begun treating cancer patients with the TomoTherapy Hi•Art treatment system, which uses CT to guide radiotherapy. Centre Oscar Lambret has ordered two such systems. The second is scheduled for installation later this year. Five other centers in France have adopted TomoTherapy's advanced cancer treatment technology: Institut Curie in Paris, Institut Bergonié in Bordeaux, Centre Paul Strauss in Strasbourg, Centre René Gauducheau in Saint Herblain, and Institut Claudius Regaud in Toulouse. Their embrace of the product comes in the wake of a July 2005 call for research proposals launched by the Institut National du Cancer to promote implementation of image-guided radiotherapy.

Epix shakes up business leadership

Chen Schor has resigned as chief business officer of Epix Pharmaceuticals. The company's former head of business development and current vice president of discovery and manufacturing, Sheila DeWitt, Ph.D., will lead the company's business development efforts, according to Epix. Schor became chief business officer in August 2006 following the company's merger with Predix. He was one of the lead investors in Predix Pharmaceuticals when the company incorporated in 2000. Schor will leave Epix effective March 23. His replacement has led efforts to reacquire worldwide rights to the Epix blood-pool MR contrast agent, Vasovist, following the decision of the company to pursue therapeutic agents in the Predix pipeline. DeWitt has also worked on arrangements to monetize rights to Vasovist, following its FDA approval.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.